Skip Navigation LinksHome > March 2008 - Volume 108 - Issue 3 > Nitrous Oxide Remains a Valuable Adjuvant for Surgery
Anesthesiology:
doi: 10.1097/ALN.0b013e3181650e8f
Correspondence

Nitrous Oxide Remains a Valuable Adjuvant for Surgery

White, Paul F. Ph.D., M.D., F.A.N.Z.C.A.*; Wender, Ronald H. M.D.

Free Access
Article Outline
Collapse Box

Author Information

Back to Top | Article Outline

To the Editor:—

Myles et al.1 have presented the results of a large prospective multicenter trial evaluating the use of nitrous oxide in patients undergoing major surgery.1 The study did not achieve its primary endpoint; therefore, the authors chose to emphasize the differences in the secondary outcome measures (e.g., postoperative nausea and vomiting [PONV]). The failure to control for anesthesia-related factors that can influence the incidence of PONV (e.g., volatile anesthetics, opioid analgesics, reversal drugs, amount of intravenous fluid administered during and after surgery, use of prophylactic and rescue antiemetics) may render the conclusion regarding the effects of nitrous oxide on PONV invalid. In addition, the relative risk of the patients for developing PONV (e.g., history of PONV, motion sickness, nonsmoking status, postoperative opioid use) were not reported in the description of the demographic characteristics of the two study groups.
These factors are particularly important in interpreting the validity of these findings because the differences in their secondary outcome variables were the end result of multiple statistical comparisons. Furthermore, several well-controlled studies involving patients undergoing ambulatory (and short-stay) surgical procedures have not found any clinically significant differences between patients receiving or not receiving nitrous oxide during surgery.2–5 Therefore, before condemning a valuable anesthetic adjuvant with well-characterized amnestic, anesthetic, and opioid-sparing effects,6 more tightly controlled studies are needed. It is potentially misleading to readers to present conclusions based on poorly controlled secondary outcome variables.1
Paul F. White, Ph.D., M.D., F.A.N.Z.C.A.,*
Ronald H. Wender, M.D.
*University of Texas Southwestern Medical Center, Dallas, Texas. paul.white@utsouthwestern.edu
Back to Top | Article Outline

References

1. Myles PS, Leslie K, Chan MT, Forbes A, Paech MJ, Peyton P, Silbert BS, Pascoe E, ENIGMA Trial Group: Avoidance of nitrous oxide for patients undergoing major surgery: A randomized controlled trial. Anesthesiology 2007; 107:221–31

2. Taylor E, Feinstein R, White PF, Soper N: Anesthesia for laparoscopic cholecystectomy: Is nitrous oxide contraindicated? Anesthesiology 1992; 76:541–3

3. Jensen AG, Prevedoros H, Kullman E, Anderberg B, Lennmarken C: Peroperative nitrous oxide does not influence recovery after laparoscopic cholecystectomy. Acta Anaesthesiol Scand 1993; 37:683–6

4. Tang J, Chen L, White PF, Wender RH, Naruse R, Kariger R, Sloninsky A: Use of propofol for office-based anesthesia: Effect of nitrous oxide on recovery profile. J Clin Anesth 1999; 11:226–30

5. Ichinohe T, Kaneko Y: Nitrous oxide does not aggravate postoperative emesis after orthognathic surgery in female and nonsmoking patients. J Oral Maillofac Surg 2007; 65:936–9

6. Smith I: Nitrous oxide in ambulatory anaesthesia: Does it have a place in day surgical anaesthesia or is it just a threat for personnel and the global environment? Curr Opin Anaesthesiol 2006; 19:592–6

© 2008 American Society of Anesthesiologists, Inc.

Publication of an advertisement in Anesthesiology Online does not constitute endorsement by the American Society of Anesthesiologists, Inc. or Lippincott Williams & Wilkins, Inc. of the product or service being advertised.
Login

Article Tools

Share